ArticleScientific reports2025

Effects of venetoclax, a BCL2 inhibitor, in systemic chronic active Epstein-Barr virus disease.

Ayaka Ohashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.